...
首页> 外文期刊>Advances in virology >Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors
【24h】

Bimolecular Complementation to Visualize Filovirus VP40-Host Complexes in Live Mammalian Cells: Toward the Identification of Budding Inhibitors

机译:双分子互补可视化活哺乳动物细胞中的filovirus VP40-宿主复合物:对萌芽抑制剂的鉴定。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Virus-host interactions play key roles in promoting efficient egress of many RNA viruses, including Ebola virus (EBOV or "e") and Marburg virus (MARV or "m"). Late- (L-) domains conserved in viral matrix proteins recruit specific host proteins, such as TsglOl and Nedd4, to facilitate the budding process. These interactions serve as attractive targets for the development of broad-spectrum budding inhibitors. A major gap still exists in our understanding of the mechanism of filovirus budding due to the difficulty in detecting virus-host complexes and mapping their trafficking patterns in the natural environment of the cell. To address this gap, we used a bimolecular complementation (BiMC) approach to detect, localize, and follow the trafficking patterns of eVP40-Tsgl01 complexes in live mammalian cells. In addition, we used the BiMC approach along with a VLP budding assay to test small molecule inhibitors identified by in silico screening for their ability to block eVP40 PTAP-mediated interactions with TsglOl and subsequent budding of eVP40 VLPs. We demonstrated the potential broad spectrum activity of a lead candidate inhibitor by demonstrating its ability to block PTAP-dependent binding of HIV-1 Gag to TsglOl and subsequent egress of HIV-1 Gag VLPs.
机译:病毒与宿主的相互作用在促进许多RNA病毒(包括埃博拉病毒(EBOV或“ e”)和马尔堡病毒(MARV或“ m”))的有效释放中起关键作用。病毒基质蛋白中保守的晚期(L-)结构域募集特定的宿主蛋白,例如Tsg101和Nedd4,以促进出芽过程。这些相互作用是广谱萌芽抑制剂发展的诱人目标。由于难以检测病毒-宿主复合物并难以在细胞的自然环境中标绘其运输模式,因此我们对丝状病毒萌芽机理的认识仍然存在很大差距。为了解决这个空白,我们使用了双分子互补(BiMC)方法来检测,定位和跟踪活哺乳动物细胞中eVP40-Tsgl01复合物的运输模式。此外,我们将BiMC方法与VLP萌芽试验一起使用,以测试通过计算机筛选鉴定的小分子抑制剂阻断eVP40 PTAP介导的与Tsg101相互作用的能力以及随后eVP40 VLP萌芽的能力。我们通过展示其阻断HIV-1 Gag与Tsg101的PTAP依赖性结合以及随后HIV-1 Gag VLP释放的能力,证明了潜在的潜在候选候选药物的广谱活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号